background
respiratori
infect
common
infect
human
preval
respiratori
virus
adult
larg
underestim
relev
data
mostli
concern
infant
children
object
evalu
preval
respiratori
virus
adult
hospit
itali
studi
design
april
consecut
lower
respiratori
tract
sampl
prospect
collect
evalu
molecular
panel
detect
respiratori
virus
result
two
hundr
fifteen
sampl
posit
least
one
viral
pathogen
overal
sampl
preval
human
rhinovirus
hrv
commonli
detect
virus
follow
influenza
viru
flu
virus
less
multipl
agent
detect
sampl
patient
result
coinfect
rate
conclus
studi
show
high
preval
virus
lower
respiratori
tract
sampl
hospit
adult
mostli
hrv
flua
possibl
establish
role
virus
detect
low
frequenc
find
suggest
necess
consid
potenti
caus
precursor
lower
respiratori
tract
infect
lrti
etiolog
lower
respiratori
tract
infect
lrti
adult
import
caus
morbid
remain
undetermin
case
fine
et
al
garbino
et
al
file
mostli
due
limit
diagnost
procedur
preval
respiratori
virus
adult
larg
unexplor
relev
data
concern
infant
children
choi
et
al
costa
et
al
kusel
et
al
et
al
orda
et
al
pierang
et
al
respiratori
syncyti
viru
rsv
parainfluenzavirus
piv
influenzavirus
flu
adenovirus
adv
consid
lead
caus
acut
viral
lrti
henderson
et
al
hall
et
al
yun
et
al
hong
et
al
howev
mani
respiratori
virus
recent
identifi
possibl
caus
agent
lrti
human
rhinovirus
hrv
previous
believ
caus
mild
upper
respiratori
ill
found
associ
acut
chronic
lrti
includ
asthma
exacerb
chronic
obstruct
pulmonari
diseas
copd
although
role
caus
agent
establish
asthma
singh
buss
papadopoulo
et
al
friedland
buss
xatzipsalti
et
al
newli
discov
virus
human
metapneumoviru
hmpv
human
coronavirus
hcov
associ
lrti
children
van
den
hoogen
et
al
fouchier
et
al
van
der
hoek
et
al
choi
et
al
aim
studi
assess
point
preval
full
spectrum
respiratori
virus
lower
respiratori
tract
specimen
hospit
adult
use
molecular
diagnost
panel
prospect
collect
lower
respiratori
sampl
adult
patient
pulmonari
diseas
admit
three
italian
hospit
perform
clinicalepidemiolog
data
collect
standard
questionnair
patient
suspect
mycobacterium
tuberculosi
infect
includ
analysi
studi
approv
institut
ethic
committe
inform
consent
sign
particip
select
criterion
patient
enrol
one
follow
sampl
sent
laboratori
routin
microbiolog
evalu
sputum
sp
bronchoalveolar
lavag
bal
endotrach
aspir
ea
minim
possibl
posit
result
reflect
contamin
upper
respiratori
tract
sampl
contain
polymorphonuclear
leucocyt
per
field
process
murray
washington
geckler
et
al
less
sampl
meet
criterion
discard
half
sampl
submit
standard
microbiolog
analysi
common
microbiolog
cultur
case
posit
result
identif
antibodi
suscept
test
remaind
store
c
molecular
analysi
april
total
consecut
lower
tract
respiratori
sampl
sp
ea
bal
consid
appropri
basi
microscop
inspect
analyz
sampl
thaw
liquefi
use
sputasol
oxoid
ltd
basingstok
england
underw
dnarna
extract
boom
et
al
rna
revers
transcrib
random
primer
revers
transcriptas
kit
invitrogen
milan
itali
control
dna
globin
dna
rna
phage
genom
prepar
spike
sampl
extract
control
suitabl
pcrrtpcr
molecular
diagnost
panel
includ
flua
b
hmpv
adv
rsv
hrv
specif
primer
pcr
rtpcr
condit
previous
describ
allard
et
al
pitkaranta
et
al
echevarria
et
al
et
al
allard
et
al
steining
et
al
maggi
et
al
fouchier
et
al
bastien
et
al
esper
et
al
woo
et
al
minoss
et
al
sensit
assay
rang
copi
flua
adv
rsv
hrv
copi
flub
hmpv
copi
sensit
valu
establish
probit
analysi
plasmid
contain
target
region
insert
confirm
particip
qualiti
control
molecular
diagnost
extern
qualiti
assur
qcmd
eqa
programm
glasgow
uk
hmpv
qcmd
eqa
programm
determin
sensit
hmpv
b
test
much
lower
time
respiratori
virus
amplifi
product
separ
agaros
gel
electrophoresi
uvvisu
ethidium
bromid
stain
molecular
diagnost
panel
detect
virus
appli
lower
respiratori
sampl
adult
patient
hospit
pulmonari
diseas
common
respiratori
ill
patient
copd
pneumonia
acut
respiratori
ill
ari
patient
intens
care
unit
receiv
assist
ventil
tabl
two
hundr
fifteen
specimen
posit
respiratori
viru
tabl
common
virus
hrv
flua
frequenc
virus
rang
sampl
correspond
patient
one
viru
detect
multipl
detect
includ
hrv
flua
total
sampl
hrv
flub
hrv
combina
tion
hrv
hrv
adv
hrv
hrv
rsv
flua
adv
hrv
flua
hrv
flua
adv
combin
associ
sampl
type
either
ea
sp
bal
could
evalu
frequent
virus
ie
flua
hrv
show
hrv
flua
unevenli
distribut
frequent
sp
bal
ea
tabl
data
smoke
statu
avail
patient
frequenc
patient
posit
viru
similar
smoker
nonsmok
vs
p
frequenc
individu
virus
significantli
differ
accord
smoker
statu
instanc
hrv
posit
patient
smoker
nonsmok
p
addit
similar
frequenc
virusposit
sampl
obtain
compar
patient
copd
vs
patient
without
copd
vs
patient
pneumonia
vs
subject
record
pneumonia
case
patient
ari
vs
subject
without
ari
vs
p
addit
frequenc
virusposit
sampl
significantli
differ
among
patient
pneumonia
copd
ari
p
monthli
distribut
respiratori
agent
studi
period
fig
highlight
peak
januaryfebruari
hrv
flua
mani
report
highlight
possibl
role
virus
caus
agent
possibl
cofactor
lrti
appli
larg
molecular
diagnost
panel
includ
respiratori
virus
evalu
preval
respiratori
pathogen
adult
hospit
itali
april
although
would
unabl
detect
viral
respiratori
pathogen
bocaviru
coronaviru
parainfluenzaviru
first
extens
investig
lower
respiratori
tract
secret
adult
capabl
detect
wide
select
respiratori
pathogen
made
assumpt
sampl
repres
lower
respiratori
tract
recogn
microscop
inspect
criterion
use
valid
qualiti
howev
expector
sputum
necessarili
contamin
oral
content
possibl
rule
viru
detect
sampl
mainli
sp
could
actual
deriv
contamin
upper
respiratori
tract
secret
fact
rate
posit
sp
higher
ea
bal
vs
respect
howev
case
virus
ie
flua
addit
presenc
sever
virus
flua
hrv
ea
bal
suggest
contamin
oral
secret
major
sourc
viru
present
analyz
sampl
result
confirm
previou
data
hrv
frequent
virus
lower
respiratori
tract
sampl
garbino
et
al
puro
et
al
strongli
support
associ
hrv
lrti
alreadi
hypothes
previou
studi
base
upper
respiratori
sampl
tsolia
et
al
howev
base
present
data
possibl
establish
precis
role
hrv
lead
caus
well
possibl
involv
cofactor
lrti
among
virus
account
posit
sampl
detect
sampl
involv
hcov
name
lower
respiratori
diseas
larg
hypothes
avail
data
mostli
base
upper
respiratori
sampl
mostli
basi
studi
pediatr
patient
arden
et
al
bastien
et
al
boivin
et
al
chiu
et
al
ebihara
et
al
moe
et
al
pierang
et
al
circul
itali
probabl
underreport
one
report
concern
viru
lower
respiratori
sampl
adult
gerna
et
al
detect
hmpv
patient
although
rel
common
respiratori
pathogen
van
den
hoogen
et
al
choi
et
al
absenc
hmpv
probabl
due
low
sensit
rtpcr
assay
use
studi
particularli
hmpv
b
altern
possibl
sputasol
use
liquefi
sampl
could
affect
sensit
rtpcr
use
issu
could
also
appli
virus
investig
studi
rsv
need
investig
conclus
studi
show
high
preval
virus
especi
hrv
influenza
viru
lower
respiratori
tract
sampl
adult
hospit
patient
pulmonari
diseas
without
signific
differ
frequenc
virusposit
among
patient
pneumonia
copd
ari
addit
virus
detect
low
frequenc
possibl
establish
role
virus
detect
low
frequenc
caus
agent
cofactor
lrti
result
highlight
necess
consid
potenti
caus
lrti
